| Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery (NCT07235098) | Oncology Institute of Southern Switzerland | 2026-06-19 |
| LUCINAE Registry: Thoracic Cancers During Pregnancy (NCT07699861) | Oncology Institute of Southern Switzerland | 2026-06-01 |
| Lifestyle Intervention in Patients With Metastatic Prostate Cancer (NCT05850182) | Oncology Institute of Southern Switzerland | 2023-11-27 |
| Metronidazole as Preoperative Therapy in CRC / FusoMetro-001 (NCT05748145) | Oncology Institute of Southern Switzerland | 2023-09-11 |
| The Immune Landscape of Epithelial Ovarian Cancer (NCT05984875) | Oncology Institute of Southern Switzerland | 2022-12-20 |
| Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC (NCT04549428) | Oncology Institute of Southern Switzerland | 2020-10-01 |
| Tumor Molecular Profiling in Early Phase Clinical Trials (NCT04510766) | Oncology Institute of Southern Switzerland | 2020-10-01 |
| Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer (NCT04543799) | Oncology Institute of Southern Switzerland | 2020-09-24 |
| Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients (NCT04790266) | Oncology Institute of Southern Switzerland | 2020-09-15 |
| Prevalence of Wild Type ATTR (NCT03966105) | Oncology Institute of Southern Switzerland | 2019-11-01 |
| A Prognostic Tool for Early Stage CLL (NCT03436524) | Oncology Institute of Southern Switzerland | 2018-03-01 |
| Personalized Risk Stratification Model of Follicular Lymphoma Patients (NCT03436602) | Oncology Institute of Southern Switzerland | 2018-03-01 |
| Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients (NCT03408964) | Oncology Institute of Southern Switzerland | 2017-12-15 |
| Liquid Biopsy in Mature B-cell Tumors (NCT03280394) | Oncology Institute of Southern Switzerland | 2017-09-01 |
| Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells (NCT03274778) | Oncology Institute of Southern Switzerland | 2017-09-01 |
| Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia (NCT02827617) | Oncology Institute of Southern Switzerland | 2016-06-01 |
| Hypofractionated Brain Radiationcavity (NCT03561896) | Oncology Institute of Southern Switzerland | 2015-01-01 |
| External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases (NCT00637637) | Oncology Institute of Southern Switzerland | 2007-09-01 |
| OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation (NCT00439127) | Oncology Institute of Southern Switzerland | 2005-01-01 |